Poly-Med has recently been in collaboration with Queensland University of Technology to promote research of our unique, bioresorbable medical grade 3D printing filaments. The latest publication, authored by Mina Mohseni, Professor Dietmar Hutmacher, and Dr. Nathan Castro, highlights performance of these filaments in fused filament fabrication (FFF) additive manufactured (AM) tissue scaffolding. Specifically, this research […]

After publishing a draft guidance document for additive manufacturing medical devices in 2016, the FDA issued its highly anticipated Technical Considerations for Additive Manufactured Medical Devices in December 2017. The latest volume on 3D-printed devices focuses heavily on advising manufacturers on 3D-printing-specific focus areas to consider when developing a new additive manufactured device. The guidance […]

In 2018, Poly-Med will celebrate its 25th anniversary. My father, our founder, Dr. Shalaby Shalaby is considered one of the forefathers in the bioresorbable polymer industry. In the late 1970’s he led an exploratory group on polymers for biomedical applications at a large medical device company. During that time, he was one the lead inventors […]

We’ve included a portion of the press release from Clemson University about a recent announcement featuring a new initiative: Materials Assembly and Design Excellence (MADE) in South Carolina. Poly-Med is proud to be a partner in this statewide initiative. CLEMSON, South Carolina — South Carolina’s position as a national leader in advanced materials just got […]

ASTM International standards are widely recognized for industry-leading work on creating consistency and supporting traceability for medical device development. The tagline “Helping Our World Work Better” is an excellent description of purpose. In reality, ASTM International is a volunteer organization where industry and academic collaborators develop standards to guide users in the selection, use, and […]